CordenPharma's Highly Potent Oral Solid Drug Product Centre of Excellence in CordenPharma Plankstadt (DE). "This is an extremely important and significant investment for CordenPharma Plankstadt. The new CTD 4 facility will bridge the gap between our small-scale GMP and larger commercial production facilities.
Цааш унших
CordenPharma Colorado's new GMP peptide expansion will complement and strengthen the existing large-scale manufacturing capabilities. Skip to content. What You Need. Integrated Supply. ... CordenPharma Colorado has grown a strong focus in the development & manufacturing of APIs from laboratory-scale to commercialization at ton-scale, due to ...
Цааш унших
The GMP manufacturing area will produce peptide APIs from gram to kilogram range for clinical Phase I and Phase II requirements with later transfer to the company's late …
Цааш унших
CordenPharma has announced the commissioning of new GMP capacities at its Frankfurt site to manufacture early clinical phase peptide APIs. The investment is still being …
Цааш унших
CordenPharma executives interview new Private Equity owners Astorg on joint plans to strengthen CAPEX, operations and CDMO strategy. ... Secondly, it has a leadership position in its most strategic platforms such as lipids, peptides, and highly potent APIs. It has a very specific and distinctive one-stop-shop offering, with end-to-end ...
Цааш унших
CordenPharma is a leading CDMO for GMP API manufacturing of peptides, oligos, HPAPIs and small molecules. Partner with us for your API manufacturing needs.
Цааш унших
APIs. API Support Services; Flow Chemistry; Solid State; Purification; Drug Products. ... Our Lipid NanoParticle (LNP) formulation development and GMP manufacturing services range from clinical to commercial supply, fully integrated with aseptic fill and finish sterile injectable manufacturing capacities, all within the same site ...
Цааш унших
Trust CordenPharma's synthetic lipid manufacturing expertise, including LNP formulation for mRNA/gene therapy, high quality catolog lipids & carbohydrates. ... such as longer shelf-life to give your API formulations a competitive advantage. ... (PAT). We offer a unique back integration of non-GMP raw materials to support your carbohydrate projects.
Цааш унших
Take a look inside the construction of our new API development building at CordenPharma Bergamo. This state-of-the-art facility covers a full range of services and activities from API process assessment & development at laboratory scale through to scale-up and subsequent transfer of our customers' processes into commercial facilities.
Цааш унших
CordenPharma's CEO reports record 2022 growth and new 2023 CAPEX expansion in peptides, Lipid NanoParticle Formulation & oligonucleotides. ... strategies that drive CordenPharma as a leading CDMO for the development and manufacturing of complex modalities for APIs, Lipid Excipients and Drug Products. ... we kicked-off strategic investments at ...
Цааш унших
This video presents our new cGMP Lipid NanoParticle (LNP) manufacturing facility in Caponago, Italy. The FDA / EMA approved site builds on decades of sterile injectable experience and fully supplements our already …
Цааш унших
At CPHI Milan 2024, Outsourcing-Pharma interviewed Dr. Brittany L. Hayes, Director, Global Highly Potent & Oncology Platform and Dr. Ilia Freifeld, Director, Global Small Molecules Platform on how CordenPharma addresses the challenges and synergies in API and Drug Product development, including innovative technologies such as spray drying, hot ...
Цааш унших
CordenPharma is a full-service CDMO for the global market, providing expert support for the development and manufacturing of APIs, Excipients, Drug Products, and associated Packaging Services. ... scale-up and commercial cGMP manufacturing of APIs, Drug Products, and Lipid Excipients. 11 Manufacturing Facilities.
Цааш унших
The GMP manufacturing area is designed to produce peptide APIs from gram to kilogram range for clinical phase 1 and 2 requirements. CordenPharma Boosts Peptide API Production with …
Цааш унших
CordenPharma Bergamo (IT) is a cGMP manufacturer of APIs, advanced pharmaceutical intermediates, and custom lipids, specializing in the large-scale commercial manufacturing of APIs for distribution on a global scale. ... CordenPharma Frankfurt supplies seamless integration with our larger scale GMP peptide manufacturing site CordenPharma ...
Цааш унших
6 March 2024 – Basel, Switzerland > After an initial expansion of the CordenPharma Frankfurt site for non-GMP manufacturing in 2020, and because of sustained success and exemplary performance delivered by their expert team, CordenPharma is pleased to announce the commissioning of new GMP capacities at Frankfurt to manufacture early clinical phase peptide …
Цааш унших
CordenPharma supports your complex API needs with extensive capabilities and capacities to produce a range of APIs. Our robust CDMO global operations enable the manufacture of early-phase clinical needs from gram scale all the way through to multi-metric ton commercial supply, with built-in geographic redundancy. ...
Цааш унших
The CordenPharma Solid State Centre of Excellence, located at our Liestal, Switzerland site, provides extensive solid-state API development support services tailored to your project needs. Our dedicated team of crystallization process and solid-state form experts, combined with the latest technology and equipment, allows for a bespoke offering that …
Цааш унших
Harnessing the collective expertise of teams across our globally-integrated cGMP facility network, we provide bespoke outsourcing services spanning the complete supply chain of APIs, drug …
Цааш унших
Even with the first quarter already complete, I wish everyone a good start to 2024! Personally, since this year marks my 10th anniversary at CordenPharma, I am taking some time to reflect on our CDMO journey over the last decade, and how grateful I feel to be working with such enthusiastic, dedicated and committed teams across Europe and the US.
Цааш унших
CordenPharma is the CDMO partner you need for the reliable supply of complex modalities along your drug development lifecycle. Harnessing the collective expertise of teams across our globally-integrated cGMP facility network, we provide bespoke outsourcing services spanning the complete supply chain of APIs, drug products and lipid excipients from early clinical-phase …
Цааш унших
CordenPharma is a leading CDMO for GMP API manufacturing of peptides, oligos, HPAPIs and small molecules. Partner with us for your API manufacturing needs.
Цааш унших
When it comes to small molecule outsourcing, choosing a reliable, flexible and robust CDMO is crucial for securing your supply chain. With a proven track record and decades of expertise, our Small Molecules platform provides comprehensive small molecule API and drug product development and manufacturing across a wide range of commercial therapeutics.
Цааш унших
CordenPharma Announces Entry into Oligonucleotide Manufacturing with Two-phase Investment at CordenPharma Colorado. 2 May 2023 – Basel > Leveraging decades of solid-phase peptide manufacturing …
Цааш унших
CordenPharma has announced the commissioning of new GMP capacities at Frankfurt to manufacture early clinical phase peptide APIs for pharma and biotech customers. …
Цааш унших
My name is Gudrun Schumacher, and I joined CordenPharma in January 2023 as the Global Head of Human Resources. Over the past few months, I have had the chance to speak with many colleagues to gain a deeper understanding of CordenPharma's people, brand, culture, mission, and value proposition to customers as full-service CDMO.
Цааш унших
CDMO CordenPharma invests a record ~€900m over 3 years in large-scale GMP peptide manufacturing expansion for growing GLP-1 peptide agonist market. Skip to content. ... reinforcing it as a market leader in the integrated supply of small to large-scale services from APIs to Drug Products (for both Injectable and Oral Peptides). 16 July 2024 ...
Цааш унших
Selecting the right cGMP contract manufacturer to produce your final manufactured and packaged drug product is an important decision. As your CDMO partner, we provide development and manufacturing services for oral solid dose (OSD), non-sterile liquid and rectal dosage forms, and parenteral dosage forms for all phases of clinical development through commercialization.
Цааш унших
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Цааш унших
Following remarkable growth, CordenPharma announces the launch of enhanced GMP capacities in Frankfurt, aiming to streamline peptide-based drug development for pharma …
Цааш унших
Interview on CordenPharma Lisbon's environmental sustainability & drug product manufacturing capacity for tablets, capsules & ointments.
Цааш унших
Formed as the global pharmaceutical service & manufacturing platform of International Chemical Investors Group in 2006, CordenPharma is your full-service partner in the Contract …
Цааш унших
CordenPharma is the CDMO partner you need for the reliable supply of complex modalities along your drug development lifecycle. Harnessing the collective expertise of teams across our globally-integrated cGMP facility network, we provide bespoke outsourcing services spanning the complete supply chain of APIs, drug products and lipid excipients from early clinical-phase …
Цааш унших
Partnership for the Manufacture of Lipids, pDNA / xRNA, LNP Manufacturing & Injectables. CordenPharma and WACKER have formed a strategic partnership to create a unique, fully-integrated service covering the complete supply chain from early clinical to commercial stage development and manufacturing of xRNA-based vaccines and gene therapies, including final …
Цааш унших
The GMP manufacturing area is designed to produce peptide APIs from gram to kilogram range for clinical phase 1 and 2 requirements. Lipids & Carbohydrates Platform: Investments to Drive the Creation of New Complex Modalities ... Phase 2 includes the design and construction of a larger GMP manufacturing facility at CordenPharma Chenôve, with a ...
Цааш унших
